Induction of apoptosis and growth arrest in human breast carcinoma cells by a Snake (Walterinnesia aegyptia) venom combined with silica nanoparticles: Crosstalk between Bcl2 and caspase 3

Cellular Physiology and Biochemistry

Volumn 30, Issue 3, 2012, Pages 653-665

  Al Sadoon, Mohamed K ^a   Abdel Maksoud, Mostafa A ^a   Rabah, Danny M ^b   Badr, Gamal ^b,c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c Assiut University   (Egypt)

Author keywords

Apoptosis; Cell Signaling; Cytoskeleton; Nanoparticles; Snake Venom

Indexed keywords

CASPASE 3; CHEMOKINE RECEPTOR CXCR4; LIPOCORTIN 5; NANOPARTICLE; PROTEIN BCL 2; SILICA NANOPARTICLE; SNAKE VENOM; UNCLASSIFIED DRUG; WALTERINNESIA AEGYPTIA VENOM;

ACTIN POLYMERIZATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING ASSAY; BREAST CARCINOMA; BREAST CELL; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL CYCLE ARREST; CONTROLLED STUDY; CYTOSKELETAL REARRANGEMENT; CYTOSKELETON; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MUS; WALTERINNESIA AEGYPTIA;

EID: 84864401186     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000341446     Document Type: Article

References (38)

1. Edlich RF, Winters KL, Lin KY: Breast cancer and ovarian cancer genetics. J Long Term Eff Med Implants 2005;15:533-545.
2. Lorusso G, Rüegg C: New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol 2012;22:226-233.
3. Arai M, Taki K, Iwase H, Takizawa K, Nishimura S: Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer. Gan To Kagaku Ryoho 2012;39:525-531.
4. Brown S, Khan DR: The treatment of breast cancer using liposome technology. J Drug Deliv 2012;2012:212965.
5. Kim YH, Lee BJ, Lee KJ, Cho JH: A case of pituitary metastasis from breast cancer that presented as left visual disturbance. J Korean Neurosurg Soc 2012;51:94-97.
6. Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR: Mutation of P53 in head and neck squamous cell carcinoma correlates with BCL2 expression and increased susceptibility to cisplatininduced apoptosis. Head Neck 2004;26:870-877.
7. Kouri FM, Jensen SA, Stegh AH: The role of Bcl2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond. ScientificWorldJournal 2012;2012:838916.
8. Gao Q, Yang S, Kang MQ: Influence of survivin and Bcl2 expression on the biological behavior of non-small cell lung cancer. Mol Med Report2012;5:1409- 1414.
9. Duo J, Ying GG, Wang GW, Zhang L: Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl2 and Bax regulation. Mol Med Report 2012;5:1453-1456.
10. Larsen MS, Bjerre K, Giobbie-Hurder A, Lænkholm AV, Henriksen KL, Ejlertsen B, Lykkesfeldt AE, Rasmussen BB: Prognostic value of Bcl2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy. Acta Oncol 2012;51:781-789.
11. Wen P Y, Kesari S: Malignant gliomas in adults. N Engl J Med 2008;359:492-507.
12. Seo HS, Choi HS, Kim SR, Choi YK, Woo SM, Shin I, Woo JK, Park SY, Shin YC, Ko SK: Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFKB signaling in HER2-overexpressing breast cancer cells. Mol Cell Biochem 2012;366:319-334.
13. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M: Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 1999;274:22932-22940.
14. Kedrin D, van Rheenen J, Hernandez L, Condeelis J, Segall JE: Cell motility and cytoskeletal regulation in invasion and metastasis. J Mammary Gland Biol Neoplasia 2007;12:143-152.
15. Urra H, Torres VA, Ortiz RJ, Lobos L, Díaz MI, Díaz N, Härtel S, Leyton L, Quest AF: Caveolin-1-enhanced motility and focal adhesion turnover require tyrosine-14 but not accumulation to the rear in metastatic cancer cells. PLoS One 2012;7:e33085.
16. Le Clainche C, Carlier MF: Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 2008;88:489-513.
17. Wozniak MA, Modzelewska K, Kwong L, Keely PJ: Focal adhesion regulation of cell behavior. Biochim Biophys Acta 2004;1692:103-119.
18. Pollard TD: The cytoskeleton cellular motility and the reductionist agenda. Nature 2003;422:741-745.
19. Liu J, Zhang D, Luo W, Yu J, Li J, Yu Y, Zhang X, Chen J, Wu XR, Huang C: E3 Ligase Activity of XIAP RING Domain Is Required for XIAP-Mediated Cancer Cell Migration, but Not for Its RhoGDI Binding Activity. PLoS One 2012;7:e35682.
20. Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, Alshatwi AA, Jyothi A, Munshi A: Artemisia absinthium (AA): a novel potential complementary and alternative medicine for breast cancer. Mol Biol Rep 2012;39:7373-7379.
21. Abu Bakar MF, Mohamad M, Rahmat A, Burr SA, Fry JR: Cytotoxicity, cell cycle arrest, and apoptosis in breast cancer cell lines exposed to an extract of the seed kernel of Mangifera pajang (bambangan). Food Chem Toxicol 2010;48:1688-1697.
22. Zhang N, Kong X, Yan S, Yuan C, Yang Q: Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis. Cancer Sci 2010;101:2375-2383.
23. El Hakim AE, Gamal-Eldeen AM, Shahein YE, Mansour NM, Wahby AF, Abouelella AM: Purification and characterization of a cytotoxic neurotoxin-like protein from Naja haje haje venom that induces mitochondrial apoptosis pathway. Arch Toxicol 2011;85:941-952.
24. Francis S, Markland A: Novel S nake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model. Haemostasis 2001;31:183-191.
25. Badr G, Borhis G, Treton D, Moog C, Garraud O, Richard Y: HIV type 1 glycoprotein 120 inhibits human B cell chemotaxis to CXC chemokine ligand (CXCL) 12, CC chemokine ligand (CCL) 20, and CCL21. J Immunol 2005;175:302-310.
26. Alama A, Bruzzo C, Cavalieri Z, Forlani A, Utkin Y, Casciano I, Romani M: Inhibition of the nicotinic acetylcholine receptors by cobra venom a-neurotoxins: is there a perspective in lung cancer treatment? PLoS One 2011;6: e20695.
27. Park MH, Son DJ, Kwak DH, Song HS, Oh KW, Yoo HS, Lee YM, Song MJ, Hong JT: Snake venom toxin inhibits cell growth through induction of apoptosis in neuroblastoma cells. Arch Pharm Res 2009;32:1545-1554.
28. Badr G, Al-Sadoon MK, El-Toni AM, Daghestani M: Walterinnesia aegyptia venom combined with silica nanoparticles enhances the functioning of normal lymphocytes through PI3K/AKT, NFKB and ERK signaling. Lipids Health Dis 2012;15:11-27.
29. Rajah TT, Peine KJ, DU N, Serret CA, Drews NR: Physiological Concentrations of Genistein and 17ß-Estradiol Inhibit MDA-MB-231 Breast Cancer Cell Growth by Increasing BAX/BCL2 and Reducing pERK1/2. Anticancer Res 2012;32:1181-1191.
30. Allen TM, Cullis PR: Drug delivery systems: Entering the mainstream. Science 2004;303:1818-1822.
31. Langer R, Tirrell DA: Designing materials for biology and medicine. Nature 2004;428:487-492.
32. Davis ME, Chen Z, Shin DM: Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Disc 2008;7:771-782.
33. Moorthi C, Manavalan R, Kathiresan K: Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci 2011;14:67-77.
34. Son DJ, Park MH, Chae SJ, Moon SO, Lee JW, Song HS, Moon DC, Kang SS, Kwon YE, Hong JT: Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor kappaB. Mol Cancer Ther 2007;6:675-683.
35. Jung S, Li C, Lee S, Ohk J, Kim SK, Lee MS, Moon HI: Inhibitory effect and mechanism on antiproliferation of khellactone derivatives from herbal suitable for medical or food uses. Food Chem Toxicol 2012;50:648-652.
36. Yamazaki D, Kurisu S, Takenawa T: Regulation of cancer cell motility through actin reorganization. Cancer Sci 2005;96:379-386.
37. Oliva IB, Coelho RM, Barcellos GG, Saldanha-Gama R, Wermelinger LS, Marcinkiewicz C, Benedeta Zingali R, Barja-Fidalgo C: Effect of RGDdisintegrins on melanoma cell growth and metastasis: involvement of the actin cytoskeleton, FAK and c-Fos. Toxicon 2007;50:1053-1063.
38. Rao J, Li N: Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets 2004;4:345-354.